Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Cornelis J. H. van de Velde"'
Autor:
Ilaria Prata, Martina Eriksson, Jasenko Krdzalic, Elma Meershoek-Klein Kranenbarg, Annet G. H. Roodvoets, Regina Beets-Tan, Cornelis J. H. van de Velde, Boudewijn van Etten, Geke A. P. Hospers, Bengt Glimelius, Per J. Nilsson, Corrie A. M. Marijnen, Koen C. M. J. Peeters, Lennart K. Blomqvist
Publikováno v:
Insights into Imaging, Vol 14, Iss 1, Pp 1-12 (2023)
Abstract Background Magnetic resonance (MR) imaging is the modality used for baseline assessment of locally advanced rectal cancer (LARC) and restaging after neoadjuvant treatment. The overall audited quality of MR imaging in large multicentre trials
Externí odkaz:
https://doaj.org/article/5ee9bb25dacb4bb7b809aee0c198cc65
Autor:
Sofieke J. D. Temmink, Koen C. M. J. Peeters, Per J. Nilsson, Anna Martling, Cornelis J. H. van de Velde
Publikováno v:
Cancers, Vol 16, Iss 8, p 1539 (2024)
Over the past decade, the treatment of rectal cancer has changed considerably. The implementation of TME surgery has, in addition to decreasing the number of local recurrences, improved surgical morbidity and mortality. At the same time, the optimisa
Externí odkaz:
https://doaj.org/article/cfc5830128cf4944947bb2bb6b440761
Autor:
Xi Zhang, Aparna Gunda, Elma Meershoek-Klein Kranenbarg, Gerrit-Jan Liefers, Badada Ananthamurthy Savitha, Payal Shrivastava, Chandra Prakash Vijay Kumar Serkad, Taranjot Kaur, Mallikarjuna Siraganahalli Eshwaraiah, Rob A. E. M. Tollenaar, Cornelis J. H. van de Velde, Caroline M. J. Seynaeve, Manjiri Bakre, Peter J. K. Kuppen
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-11 (2023)
Abstract Background Hormone receptor (HR)-positive, HER2/neu-negative breast cancers have a sustained risk of recurrence up to 20 years from diagnosis. TEAM (Tamoxifen, Exemestane Adjuvant Multinational) is a large, multi-country, phase III trial tha
Externí odkaz:
https://doaj.org/article/3d99b753ff134f63ac6057c295814442
Autor:
John M. S. Bartlett, Jane Bayani, Elizabeth Kornaga, Keying Xu, Greg R. Pond, Tammy Piper, Elizabeth Mallon, Cindy Q. Yao, Paul C. Boutros, Annette Hasenburg, J. A. Dunn, Christos Markopoulos, Luc Dirix, Caroline Seynaeve, Cornelis J. H. van de Velde, Robert C. Stein, Daniel Rea
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-13 (2021)
Abstract Multiparametric assays for risk stratification are widely used in the management of both node negative and node positive hormone receptor positive invasive breast cancer. Recent data from multiple sources suggests that different tests may pr
Externí odkaz:
https://doaj.org/article/86050652dddb40c7bbae488c081d3af4
Autor:
Danny Houtsma, Stefanie de Groot, Renee Baak-Pablo, Elma Meershoek -Klein Kranenbarg, Caroline M. Seynaeve, Cornelis J. H. van de Velde, Stefan Böhringer, Judith R. Kroep, Henk -Jan Guchelaar, Hans Gelderblom
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract The PvuII (rs2234693) Single Nucleotide Polymorphism (SNP) in the gene coding for the estrogen receptor-1 (ESR1), has been found associated with outcome in tamoxifen treated patients with early hormone-receptor positive breast cancer. Howeve
Externí odkaz:
https://doaj.org/article/7b3160633f9542b984aff99611fa5325
Autor:
Alessandro Leal, Nicole C. T. van Grieken, Doreen N. Palsgrove, Jillian Phallen, Jamie E. Medina, Carolyn Hruban, Mark A. M. Broeckaert, Valsamo Anagnostou, Vilmos Adleff, Daniel C. Bruhm, Jenna V. Canzoniero, Jacob Fiksel, Marianne Nordsmark, Fabienne A. R. M. Warmerdam, Henk M. W. Verheul, Dick Johan van Spronsen, Laurens V. Beerepoot, Maud M. Geenen, Johanneke E. A. Portielje, Edwin P. M. Jansen, Johanna van Sandick, Elma Meershoek-Klein Kranenbarg, Hanneke W. M. van Laarhoven, Donald L. van der Peet, Cornelis J. H. van de Velde, Marcel Verheij, Remond Fijneman, Robert B. Scharpf, Gerrit A. Meijer, Annemieke Cats, Victor E. Velculescu
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-11 (2020)
Identifying patients that will respond to a particular therapy remains a key challenge in precision oncology. Here, in gastric cancer, the authors show that circulating tumour DNA can predict recurrence, provided that the signal from white blood cell
Externí odkaz:
https://doaj.org/article/e873283671f243d3ba192161c80d36a7
Autor:
Marion M. Deken, Desirée L. Bos, Willemieke S. F. J. Tummers, Taryn L. March, Cornelis J. H. van de Velde, Mark Rijpkema, Alexander L. Vahrmeijer
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-10 (2019)
Abstract Background Combining modalities using dual-labeled antibodies may allow preoperative and intraoperative tumor localization and could be used in image-guided surgery to improve complete tumor resection. Trastuzumab is a monoclonal antibody ag
Externí odkaz:
https://doaj.org/article/2184bff468d144f1af4acca02ef9791e
Autor:
Astrid E. Slagter, Irene A. Caspers, Nicole C. T. van Grieken, Iris Walraven, Pehr Lind, Elma Meershoek-Klein Kranenbarg, Cecile Grootscholten, Marianne Nordsmark, Johanna W. van Sandick, Karolina Sikorska, Cornelis J. H. van de Velde, Edwin P. M. Jansen, Marcel Verheij, Hanneke W. M. van Laarhoven, Annemieke Cats
Publikováno v:
Cancers, Vol 14, Iss 12, p 2963 (2022)
(1) Background: Perioperative chemotherapy is the current standard treatment for patients with resectable gastric cancer. Based on studies in patients with metastatic gastric cancer, oxaliplatin has replaced cisplatin in the curative setting as well.
Externí odkaz:
https://doaj.org/article/49596188a96743098de626c21013fe7f
Autor:
Syed Haider, Cindy Q. Yao, Vicky S. Sabine, Michal Grzadkowski, Vincent Stimper, Maud H. W. Starmans, Jianxin Wang, Francis Nguyen, Nathalie C. Moon, Xihui Lin, Camilla Drake, Cheryl A. Crozier, Cassandra L. Brookes, Cornelis J. H. van de Velde, Annette Hasenburg, Dirk G. Kieback, Christos J. Markopoulos, Luc Y. Dirix, Caroline Seynaeve, Daniel W. Rea, Arek Kasprzyk, Philippe Lambin, Pietro Lio’, John M. S. Bartlett, Paul C. Boutros
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-12 (2018)
Accurate and actionable biomarkers that integrate diverse molecular, functional and clinical information hold great promise in precision medicine. Here, the authors develop SIMMS, a method for pathway-based cross-disease biomarker discovery.
Externí odkaz:
https://doaj.org/article/bcb37461217c4cbca56503d084f11052
Autor:
Irene A. Caspers, Karolina Sikorska, Astrid E. Slagter, Romy M. van Amelsfoort, Elma Meershoek-Klein Kranenbarg, Cornelis J. H. van de Velde, Pehr Lind, Marianne Nordsmark, Edwin P. M. Jansen, Marcel Verheij, Johanna W. van Sandick, Annemieke Cats, Nicole C. T. van Grieken
Publikováno v:
Cancers, Vol 13, Iss 18, p 4626 (2021)
Gastric cancer (GC) patients at high risk of developing peritoneal metastasis (PM) as a single site of metastasis after curative treatment may be candidates for adjuvant prophylactic strategies. Here we investigated risk factors for metachronous isol
Externí odkaz:
https://doaj.org/article/2fc53e05bb6d4289b9b010db02260128